ArticleCancer prevention research (Philadelphia, Pa.)2019

Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.

Chelsea Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.